Neurology News

In this Healio video, David G. Standaert, MD, PhD, discusses the David Marsden Presidential Lecture Award presentation given at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.

Physicians and patient advocacy groups are rallying behind a renewed legislative effort in Congress to amend what they claim are harmful step therapy practices that often delay or deny effective treatments to people with chronic conditions.

Vidofludimus calcium for relapsing-remitting MS was safe and well-tolerated in an open-label extension, with a high degree of treatment persistence, according to a poster presented at ECTRIMS 2025 in Barcelona.

Tramadol is widely prescribed for chronic pain but recently failed to meet a predefined minimal important difference threshold in a systematic review and meta-analysis published in BMJ Evidence Based Medicine.

ATLANTA — There is more evidence that shingles vaccination significantly decreases the risk for heart disease, dementia and death among people aged 50 years or older with herpes zoster infection, according to data presented at IDWeek.

Every medical innovation is usually met with both some excitement and some appropriate skepticism.

Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in high-risk adults with type 2 diabetes.

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according to the manufacturer.

ORLANDO — Ocular pain can have many causes and should not always be diagnosed as dry eye disease, according to a speaker here at Cornea Subspecialty Day at the American Academy of Ophthalmology meeting.